European Archives of Oto-Rhino-Laryngology

, Volume 271, Issue 2, pp 207–210 | Cite as

Radiofrequency ablation in advanced head and neck cancer

  • Randall P. Owen
  • Jane S. Lee
  • Carl E. Silver
  • Leif Bäck
  • Jonathan J. Beitler
  • Alessandra Rinaldo
  • Bert W. O’MalleyJr.
  • Missak HaigentzJr.
  • Alfio Ferlito
Editorial

References

  1. 1.
    Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao C, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350:1937–1944CrossRefPubMedGoogle Scholar
  2. 2.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M, European Organization for Research and Treatment of Cancer Trial 22931 (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952CrossRefPubMedGoogle Scholar
  3. 3.
    Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRefPubMedGoogle Scholar
  4. 4.
    Vermorken JB, Stöhlmacher-Williams J, Davidenko I, Licitra L, Winquist E, Villanueva C, Foa P, Rottey S, Skladowski K, Tahara M, Pai VR, Faivre S, Blajman CR, Forastiere AA, Stein BN, Oliner KS, Pan Z, Bach BA, SPECTRUM investigators (2013) Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol 14:697–710CrossRefPubMedGoogle Scholar
  5. 5.
    LeVeen RF (1997) Laser hyperthermia and radiofrequency ablation of hepatic lesions. Sem Inter Radiol 4:313–323Google Scholar
  6. 6.
    Decadt B, Siriwardena AK (2004) Radiofrequency ablation of liver tumors: systematic review. Lancet Oncol 5:550–560CrossRefPubMedGoogle Scholar
  7. 7.
    Seidenfeld J, Korn A, Aronson N (2002) Radiofrequency ablation of un-resectable primary liver cancer. J Am Coll Surg 194:813–828CrossRefPubMedGoogle Scholar
  8. 8.
    Lane MD, Le HB, Lee S, Young C, Heran MK, Badii M, Clarkson PW, Munk PL (2011) Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol 40:25–32CrossRefPubMedGoogle Scholar
  9. 9.
    Baek JH, Kim YS, Sung JY, Choi H, Lee JH (2011) Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 197:W331–W336CrossRefPubMedGoogle Scholar
  10. 10.
    Chan MD, Dupuy DE, Mayo-Smith WW, Ng T, DiPetrillo TA (2011) Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer. Brachytherapy 10:253–259CrossRefPubMedGoogle Scholar
  11. 11.
    Ohtani S, Kochi M, Ito M, Higaki K, Takada S, Matsuura H, Kagawa N, Hata S, Wada N, Inai K, Imoto S, Moriya T (2011) Radiofrequency ablation of early breast cancer followed by delayed surgical resection- a promising alternative to breast-conserving surgery. Breast 20:431–436CrossRefPubMedGoogle Scholar
  12. 12.
    Hines-Peralta A, Goldberg SN (2004) Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res 10:6328S–6334SCrossRefPubMedGoogle Scholar
  13. 13.
    Munver R, Del Pizzo JJ, Sosa RE (2003) Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland. Curr Urol Rep 4:87–92CrossRefPubMedGoogle Scholar
  14. 14.
    Carney AS, Evans AS, Mirza S, Psaltis A (2010) Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis. J Laryngol Otol 24:510–514CrossRefGoogle Scholar
  15. 15.
    Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ (2000) Radiofrequency ablation of 231 un-resectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7:593–600PubMedGoogle Scholar
  16. 16.
    Owen RP, Ravikumar TS, Silver CE, Beitler J, Wadler S, Bello J (2002) Radiofrequency ablation of head and neck tumors: dramatic results from application of a new technology. Head Neck 24:754–758CrossRefPubMedGoogle Scholar
  17. 17.
    Owen RP, Silver CE, Ravikumar TS, Brook A, Bello J, Breining D (2004) Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg 130:52–56CrossRefPubMedGoogle Scholar
  18. 18.
    Owen RP, Khan SA, Negassa A, Beitler JJ, Bello JA, Brook A, Farinhas J, Garg MK, Haigentz M Jr, Miller TS, Hsu MS, Ravikumar TS, Shifteh K, Smith RV, Silver CE (2011) Radiofrequency ablation of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 137:493–498CrossRefPubMedGoogle Scholar
  19. 19.
    Brook AL, Gold MM, Miller TS, Gold T, Owen RP, Sanchez LS, Farinhas JM, Shifteh K, Bello JA (2008) CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiol 19:725–735CrossRefPubMedGoogle Scholar
  20. 20.
    Liukko T, Mäkitie AA, Markkola A, Ylikoski J, Bäck L (2006) Radiofrequency induced thermotherapy: an alternative palliative treatment modality in head and neck cancer. Eur Arch Otorhinolaryngol 263:532–536CrossRefPubMedGoogle Scholar
  21. 21.
    Saito K, Araki K, Reddy N, Guang W, O’Malley BW Jr, Li D (2011) Enhanced local dendritic cell activity and tumor-specific immuno response in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model. Head Neck 33:359–367PubMedGoogle Scholar
  22. 22.
    Shin JE, Baek JH, Lee JH (2013) Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol 25:14–19CrossRefPubMedGoogle Scholar
  23. 23.
    Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, Marciello F, Marotta V, Del Prete M, Papini E, Lombardi G, Colao A, Spiezia S (2012) Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab 97:4439–4445CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Randall P. Owen
    • 1
  • Jane S. Lee
    • 1
  • Carl E. Silver
    • 6
  • Leif Bäck
    • 7
  • Jonathan J. Beitler
    • 2
  • Alessandra Rinaldo
    • 3
  • Bert W. O’MalleyJr.
    • 5
  • Missak HaigentzJr.
    • 4
  • Alfio Ferlito
    • 3
  1. 1.Division of Metabolic, Endocrine and Minimally Invasive Surgery, Department of SurgeryMount Sinai School of MedicineNew YorkUSA
  2. 2.Department of Radiation Oncology, Georgia Research Alliance Cancer ScientistWinship Cancer Institute Emory UniversityAtlantaUSA
  3. 3.ENT ClinicUniversity of UdineUdineItaly
  4. 4.Division of Oncology, Department of Medicine, Albert Einstein College of MedicineMontefiore Medical CenterBronxUSA
  5. 5.Department of Otorhinolaryngology-Head and Neck SurgeryThe University of Pennsylvania Health SystemPhiladelphiaUSA
  6. 6.Departments of Surgery and Otolaryngology-Head and Neck Surgery, Albert Einstein College of MedicineMontefiore Medical CenterBronxUSA
  7. 7.Department of Otorhinolaryngology-Head and Neck SurgeryHelsinki University Central HospitalHelsinkiFinland

Personalised recommendations